.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research in Nature Neuroscience clarifies how Neuropeptide Y memory extinction mechanisms operate within the brain’s hippocampal circuitry. Specifically, scientists discovered that neuropeptide Y (NPY)-expressing interneurons in the ventral CA1 (vCA1) region play a dual role. These neurons utilize fast GABA-ergic inhibition to help acquire memories. Conversely, they employ slow NPY-mediated inhibition to promote memory extinction. Consequently, this intricate process determines whether a memory remains stable or becomes malleable over time.
Moreover, researchers observed that calcium dynamics and NPY release ramp up significantly as the behavioral state switches from fear to safety. This biochemical shift is essential for successful extinction learning. By acting on non-overlapping subensembles of NPY1R- and NPY2R-expressing neurons, the peptide gates different stages of the extinction process. Therefore, these receptors serve as critical regulators of both early fast and late slow stages of behavioral adaptation.
Understanding these mechanisms provides a potential framework for treating disorders like PTSD. In addition, the study suggests that NPY is both necessary and sufficient for controlling memory extinction rates. By targeting specific NPY receptor subensembles, clinicians might eventually develop precision therapies for maladaptive fear. Thus, this neurobiological breakthrough offers hope for more effective interventions in psychiatric medicine. Similarly, future studies may explore if these pathways function identically in humans to validate these therapeutic targets.
NPY facilitates extinction by providing slow peptidergic inhibition through NPY1R and NPY2R receptors. This process helps the brain transition from a fearful state to a non-fearful one during learning sessions.
The ventral CA1 (vCA1) is a critical hub for emotional memory. It contains specific interneurons that manage the stability of fear memories and determine the rate at which they are extinguished.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional clinical judgment. Refer to the latest local and national guidelines for clinical practice.
References
Wu YJ et al. Neuropeptide Y co-opts neuronal ensembles for memory lability and stability. Nat Neurosci. 2026 Mar 31. doi: 10.1038/s41593-026-02235-x. PMID: 41917464.
Sah P, Geracioti TD. Neuropeptide Y and posttraumatic stress disorder. Mol Psychiatry. 2013;18(6):646-655.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A Nature Neuroscience study reveals how Neuropeptide Y interneurons in the hippocampus control memory extinction via specific receptor-expressing ensembles....
5 months ago
A comparative analysis shows that older age, elevated blood glucose, and abdominal adiposity are primary drivers of hypertension. Comprehensive evaluation of cardiometabolic risk profiles enables clinicians to detect overlapping metabolic dysfunctions early and optimize targeted prevention strategies.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Left ventricular thrombus is a severe complication of acute decompensated heart failure. This clinical review explores the pathophysiology, imaging challenges, and pharmacotherapeutic considerations of laminated thrombi, evaluating the evolving role of direct oral anticoagulants versus traditional warfarin.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
